ARTICLE | Clinical News
SER-287: Phase Ib started
January 4, 2016 8:00 AM UTC
Seres began a double-blind, placebo-controlled, U.S. Phase Ib trial to evaluate oral SER-287 once daily or weekly for 8 weeks, with or without pretreatment with vancomycin, in up to 55 patients. ...